Nanotech

Can the very, very small go big?

Last updated: 21 Jul 2022

Market 101

What if we could manipulate something that’s 100k times thinner than the width of paper to create new, powerful tech? What sounds like fantasy is in fact the domain of nanotechnology, where absolutely tiny materials are reshaped to create cutting edge products, like batteries that last longer, anti- cancer drugs, or filters that make polluted water drinkable.

Alongside excitement in the field, though, there are questions about just how widely and profitably this tech will be used. For now commercial nanotech is mostly limited to products that have been incrementally enhanced through the selective use of nano-enabled materials or processes. Their more revolutionary counterparts remain stuck in the lab. It will take a combo of fundamental research around matter dynamics at the nanoscale; the ability to mass-manufacture nanoparticles; and more stringent standards around testing and usage to see truly revolutionary nanotech take its long-promised leap out of the lab and into the everyday.

Early stage market map

Early stage market map

Key facts

1nm (nanometre)

one billionth of a metre — or how long our fingernails grow per second1

$8bn

global nanomaterials market in 20202

14

% projected CAGR of the global nanomaterials market from 2021-20283

Startups tracked by Sifted

Sifted take

For all the promise that nanotech holds, there are still many uncertainties when it comes to application. Cost and safety remain key concerns, both with regards to access to nanotech-based products and the risk of nanoparticles released into the environment more broadly. Rigorous testing will be central to build trust and encourage adoption.

Rising stars

Europe's leading pre-Series A startups (all published data verified) We identify companies as ‘rising stars’ using a number of criteria including founder backgrounds, investor track record, funding and valuation, and growth signals

E-magy

Alternative materials

Advanced battery materials

Total funding

€7m

Broek op Langedijk, Netherlands
2019

Based just outside of Amsterdam, E-magy uses “environmentally benign” silicon anode material to boost the performance of lithium-ion batteries. Company is backed by SHIFT Invest and PDENH.

Round

Seed


Date

2021

Size

€5m

C12 Quantum Electronics

Quantum applications

Total funding

€9.1m

Paris, France
2020

Backed by the likes of Bpifrance, 360 Capital Partners and Agoranov, C12 QE uses pure carbon nanotubes to produce quantum processors and hybrid circuits. Cofounders and twin brothers Pierre and Matthieu Desjardins have notable academic track records in the field.

Round

Seed

Valuation

€45m


Date

2021

Size

€9.1m

Remedy Biologics

Drug diagnostics & therapeutics

Total funding

€18.5m

Dublin, Ireland
2017

A European Innovation Council grant winner among 4,000 companies, Dublin-based RemedyBio develops nanoscale biotechnology for therapeutic and diagnostic discovery for different applications, including immuno-oncology and infectious diseases.

Round

Seed


Date

2021

Size

€8m

Early stage startups to watch

AlixLabs

Stångby, Sweden
2019
Seed

910k

910k

2.9m

ATLANT 3D Nanosystems

Kongens Lyngby, Denmark
2018
Seed

870k

750k

6.5m

BIOND Solutions (BI/OND)

Delft, Netherlands
2017
Seed

3.9m

2.5m

-

C12 Quantum Electronics

Paris, France
2020
Seed

9.1m

9.1m

45m

Carbon Waters

Pessac, France
2017
Seed

2.3m

770k

5.3m

E-magy

Broek op Langedijk, Netherlands
2019
Early VC

7m

5m

-

ELDICO SCIENTIFIC

Villigen, Switzerland
2019
Pre-seed

4m

2.5m

-

Gelatex Technologies

Tallinn, Estonia
2016
Seed

1.6m

1.2m

-

Infrascreen

Neuchatel, Suisse
2019
Seed

1.5m

1.5m

-

Innatera Nanosystems

Delft, Netherlands
2018
Seed

5m

5m

-

Kimialys

Paris, France
2020
Pre-seed

100k

100k

-

NUCAPS Nanotechnology

Noáin, Spain
2017
Pre-seed

2.5m

5m

-

QDI Systems

Groningen, Netherlands
2019
Seed

1.6m

1.3m

-

Remedy Biologics

Dublin, Ireland
2017
Grant

18.5m

8m

-

Your feedback

How would you rate this briefing?

1
2
3
4
5